| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Steven Leonard Chapman | CEO AND PRESIDENT | 2026-03-02 | 365 | $201.18 | $73.43kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-03-02 | 5,125 | $9.59 | $49.15kBuy |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-03-02 | 931 | $198.83 | $185.11kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-03-02 | 1,594 | $200.11 | $318.97kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-03-02 | 475 | $200.97 | $95.46kSell |
| Jonathan Sheena | Director | 2026-03-02 | 100 | $202.85 | $20.29kSell |
| Jonathan Sheena | Director | 2026-03-02 | 100 | $201.20 | $20.12kSell |
| Jonathan Sheena | Director | 2026-03-02 | 2,400 | $200.42 | $481.01kSell |
| Jonathan Sheena | Director | 2026-03-02 | 470 | $198.50 | $93.29kSell |
| Steven Leonard Chapman | CEO AND PRESIDENT | 2026-03-02 | 1,122 | $199.17 | $223.47kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jpmorgan Chase Co | 9.07% | 12,854,334 | $2.66B | Institution |
| Vanguard Group Inc | 8.68% | 12,306,424 | $2.55B | Institution |
| Price T Rowe Associates Inc | 7.67% | 10,871,989 | $2.25B | Institution |
| Blackrock Inc | 7.66% | 10,859,441 | $2.25B | Institution |
| Claremont Creek Ventures L P | 4.14% | 5,864,630 | $1.21B | Insider |
| Roelof Botha | 3.96% | 5,609,181 | $1.16B | Insider |
| Sc XII Management LLC | 3.82% | 5,421,122 | $1.12B | Insider |
| Wellington Management Group LLP | 3.51% | 4,976,325 | $1.03B | Institution |
| Matthew Rabinowitz | 3.41% | 4,839,340 | $1.00B | Insider |
| James Healy | 3.31% | 4,697,100 | $972.49M | Insider |